Abstract
Ethnicity seems to be a risk factor for asthma and its exacerbation, but no general consensus has been reached so far. Ethnic diversity and differences have long been overlooked and most studies in these regards are observational, lacking in-depth mechanistic insights.
Harnessing comprehensive transcriptomic data at organ system and single cell levels, we comparatively analyzed the signalling landscapes of African American/Black (AA) and other ethnicities. In healthy individuals, most AA PBMC subsets exhibited elevated IL2-STAT5 signals, which is critically implicated in asthma pathogenesis. This extended to various compartments (bronchial and airway epithelium, circulating CD4+ T cells and blood) in asthma, where AA upregulated IL2-STAT5 pathway relative to other ethnicities. Mechanistically, the increased IL2-STAT5 signalling correlated with enhanced T cell migration and recruitment. Together, they might contribute to the greater predisposition towards asthma exacerbation in AA.
This first-of-its-kind study sheds some in-depth insights into the biology of ethnic differences in asthma. Our findings, if further validated, will be valuable for future asthma research and clinical practice like therapeutic development and treatment guidance, highlighting the need for ethnicity diversity and inclusions in these areas.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project is supported by the Norman Ernest Bequest Fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
